Jason Luke, Chief Medical Officer at Strand Therapeutics, shared Strand Therapeutics’s post on X, adding:
“Super excited to be at SITC25!
On-going insightful BoD meeting where it’s great seeing and discussing the future of the society and cancer immunotherapy.
Hope to see all of the IO community this weekend!”
Quoting Strand Therapeutics’s post:
“This week Strand Therapeutics CMO Jason Luke is leading the Society for Immunotherapy of Cancer 40th Annual Meeting! He will be voting on the Board of Directors, Lecturing on the future of TCR therapeutics and Chairing a session on late breaking clinical abstracts.
More posts about SITC25.
